Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

CONTEXT: Circulating concentration of lipoprotein(a) (Lp[a]), a large glycoprotein attached to a low-density lipoprotein-like particle, may be associated with risk of coronary heart disease (CHD) and stroke. OBJECTIVE: To assess the relationship of Lp(a) concentration with risk of major vascular and...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Erqou, S, Kaptoge, S, Perry, P, Di Angelantonio, E, Thompson, A, White, I, Marcovina, S, Collins, R, Thompson, S, Danesh, J
Format:	Journal article
Język:	English
Wydane:	2009

Podobne zapisy

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
od: Kaptoge, S, i wsp.
Wydane: (2010)

Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality
od: Parish, S, i wsp.
Wydane: (2010)

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
od: Thompson, A, i wsp.
Wydane: (2010)

Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
od: Heart Protection Study Collaborative Group
Wydane: (2010)

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
od: Danesh, J, i wsp.
Wydane: (2005)

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.
od: Danesh, J, i wsp.
Wydane: (2000)

Risk assessment in coronary patients undergoing abdominal nonvascular surgery
od: Karapandzic Vesna, i wsp.
Wydane: (2009-12-01)

Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis.
od: Lathan Liou, i wsp.
Wydane: (2020-01-01)

Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease
od: Lisandro D. Colantonio, i wsp.
Wydane: (2022-06-01)

Major lipids, apolipoproteins, and risk of vascular disease.
od: Di Angelantonio, E, i wsp.
Wydane: (2009)

Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men.
od: Emberson, JR, i wsp.
Wydane: (2010)

Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.
od: Emanuele Di Angelantonio, i wsp.
Wydane: (2007-09-01)

A Case of Solitary Nonvascularized Corneal Epithelial Dysplasia
od: Tomoya Morii, i wsp.
Wydane: (2016-01-01)

The Fate of Nonvascularized Fat Grafts: Histological and Bioluminescent Study
od: Ataru Sunaga, MD, i wsp.
Wydane: (2013-09-01)

Nonvascular retinal imaging markers of preclinical Alzheimer's disease
od: Peter J. Snyder, i wsp.
Wydane: (2016-01-01)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
od: Hopewell, J, i wsp.
Wydane: (2011)

Hernia Correction After Liver Transplantation Using Nonvascularized Fascia
od: Iago Justo, MD, PhD, i wsp.
Wydane: (2024-07-01)

Role of percutaneous nonvascular Interventional Radiology treatments in musculoskeletal lesions
od: Deep Narayan Srivastava
Wydane: (2016-01-01)

The role of ubiquinone supplementation on osteogenesis of nonvascularized autogenous bone graft
od: Irham Taufiqurrahman, i wsp.
Wydane: (2015-03-01)

Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses
od: Sofianopoulou, E, i wsp.
Wydane: (2021)

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
od: Stefania Lamon-Fava, i wsp.
Wydane: (2011-06-01)

The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
od: Kent, S, i wsp.
Wydane: (2016)

Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults
od: Zhuang, Z, i wsp.
Wydane: (2021)

Intercalary diaphysometafisary humeral reconstruction with nonvascularized peroneal graft and external fixation
od: Yulay Enrique Hernández-Rojas, i wsp.
Wydane: (2023-07-01)

Comparison of the outcomes of vascularized and nonvascularized bone grafting in treatment of scaphoid nonunion
od: Ali Tabrizi, i wsp.
Wydane: (2022-01-01)

Donor Site Morbidity of Nonvascularized Bone Graft: A Systematic Review
od: Lilies Dwi Sulistyani, i wsp.
Wydane: (2023-06-01)

Reconstruction of mandibular defects using nonvascularized autogenous bone graft in Nigerians
od: Kizito Chioma Ndukwe, i wsp.
Wydane: (2014-01-01)

Efficiency and safety of varying the frequency of whole blood donation: randomised trial of 45,000 donors
od: Di Angelantonio, E, i wsp.
Wydane: (2017)

Association of CETP gene variants with risk for vascular and nonvascular diseases among Chinese adults
od: Millwood, I, i wsp.
Wydane: (2017)

Chronic infections and coronary heart disease: is there a link?
od: Danesh, J, i wsp.
Wydane: (1997)

Multilevel Analysis of the Neovascularization and Integration Process of a Nonvascularized Rectus Fascia Transplantation
od: Ewout Muylle, BSc, i wsp.
Wydane: (2024-06-01)

Lymphangiogenesis after nonvascularized lymph node transplantation: Lymphangiographic findings in mice and minipigs
od: Kyoung Min Kim, i wsp.
Wydane: (2023-01-01)

Exposed Artificial Plate Covered With Perifascial Areolar Tissue as a Nonvascularized Graft
od: Tomoyuki Ito, MD, i wsp.
Wydane: (2019-02-01)

Lipoprotein (a) measurements for clinical application
od: Santica M. Marcovina, i wsp.
Wydane: (2016-04-01)

Coronary heart disease and stroke mortality trends in Brazil 2000-2018.
od: Patrícia Vasconcelos Leitão Moreira, i wsp.
Wydane: (2021-01-01)

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease
od: Jin-Ming Cen, i wsp.
Wydane: (2015-06-01)

Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.
od: Kaptoge, S, i wsp.
Wydane: (2007)

Cohort profile: the BangladEsh Longitudinal Investigation of Emerging Vascular and nonvascular Events (BELIEVE) cohort study
od: Anisur Rahman, i wsp.
Wydane: (2025-01-01)

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
od: Zewinger, S, i wsp.
Wydane: (2017)

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
od: Zewinger, S, i wsp.
Wydane: (2017)